Trends in radiation protection in CT: present and future status.
J Cardiovasc Comput Tomogr
2009
3 Suppl 2
S65-73
Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography.
JACC Cardiovasc Imaging
2009
2
7
825-31
P27 and P53 gene polymorphisms and restenosis following coronary implantation of drug-eluting stents.
Cardiology
2009
112
4
263-9
Real-time 3-dimensional echocardiographic assessment of left ventricular dyssynchrony: pitfalls in patients with dilated cardiomyopathy.
JACC Cardiovasc Imaging
2009
2
7
802-12
Very late stent thrombosis 42 months after implantation of sirolimus-eluting stent and discontinuation of antiplatelet therapy.
Case Rep Med
2009
2009
713292
One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.
JACC Cardiovasc Imaging
2009
2
5
625-8
Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction.
JACC Cardiovasc Imaging
2009
2
5
580-8
No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents.
JACC Cardiovasc Interv
2009
2
11
1149-55
Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.
EuroIntervention
2009
4
4
427-36